Revive Therapeutics Stock Probability of Future OTC Stock Price Finishing Under 0.005149
| RVVTF Stock | USD 0.01 0.0009 12.86% |
Revive |
Revive Therapeutics Target Price Odds to finish below 0.005149
The tendency of Revive OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.01 or more in 90 days |
| 0.01 | 90 days | 0.01 | about 1.64 |
Based on a normal probability distribution, the odds of Revive Therapeutics to drop to $ 0.01 or more in 90 days from now is about 1.64 (This Revive Therapeutics probability density function shows the probability of Revive OTC Stock to fall within a particular range of prices over 90 days) . Probability of Revive Therapeutics price to stay between $ 0.01 and its current price of $0.0061 at the end of the 90-day period is about 14.3 .
Assuming the 90 days horizon Revive Therapeutics has a beta of 0.35 indicating as returns on the market go up, Revive Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Revive Therapeutics will be expected to be much smaller as well. Additionally Revive Therapeutics has an alpha of 0.3464, implying that it can generate a 0.35 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Revive Therapeutics Price Density |
| Price |
Predictive Modules for Revive Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Revive Therapeutics. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Revive Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Revive Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Revive Therapeutics is not an exception. The market had few large corrections towards the Revive Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Revive Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Revive Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.35 | |
β | Beta against Dow Jones | 0.35 | |
σ | Overall volatility | 0.0008 | |
Ir | Information ratio | 0.02 |
Revive Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Revive Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Revive Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Revive Therapeutics generated a negative expected return over the last 90 days | |
| Revive Therapeutics has high historical volatility and very poor performance | |
| Revive Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (17.81 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Revive Therapeutics has accumulated about 5.29 M in cash with (13.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Revive Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Revive OTC Stock often depends not only on the future outlook of the current and potential Revive Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Revive Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 321.4 M |
Revive Therapeutics Technical Analysis
Revive Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Revive OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Revive Therapeutics. In general, you should focus on analyzing Revive OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Revive Therapeutics Predictive Forecast Models
Revive Therapeutics' time-series forecasting models is one of many Revive Therapeutics' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Revive Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Revive Therapeutics
Checking the ongoing alerts about Revive Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Revive Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Revive Therapeutics generated a negative expected return over the last 90 days | |
| Revive Therapeutics has high historical volatility and very poor performance | |
| Revive Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (17.81 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Revive Therapeutics has accumulated about 5.29 M in cash with (13.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Other Information on Investing in Revive OTC Stock
Revive Therapeutics financial ratios help investors to determine whether Revive OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Revive with respect to the benefits of owning Revive Therapeutics security.